Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia
- PMID: 30535930
- DOI: 10.1007/s40266-018-0623-6
Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia
Abstract
Psychotropic medications have a high risk of serious adverse events and small effect size for changed behaviours for people with dementia. Non-pharmacological approaches are recommended as first-line treatment for changed behaviours, yet psychotropic medications remain highly prevalent in long-term aged care settings. This narrative review describes the current evidence regarding deprescribing psychotropic medications for people with dementia in long-term care. Deprescribing psychotropic medications can be achieved without harm to the person with dementia, and most people experience no withdrawal symptoms. Interventions to deprescribe psychotropic medications should be multifactorial, including lowering the dose of the medication over time, educational interventions and psychological support. However, implementing this is a significant challenge due to the overreliance on psychotropic medications for behavioural management in long-term aged care. Facilitators to deprescribing psychotropic medications in long-term care include multidisciplinary teams with adequate training, education and managerial support, engaging residents and families and change 'champions'. Deprescribing practices should be person-centred, and an individualised deprescribing protocol should be in place, followed by careful monitoring of the individual. The person with dementia and their family, general practitioner, pharmacist, and allied health and direct care staff should all be involved throughout the deprescribing process. Direct care staff need adequate support, education and training, so they can effectively help the individual and implement person-centred approaches in the absence of psychotropic medications. Effective communication between residents and staff and amongst staff is consistently shown to be an important factor for deciding whether deprescribing of a medication should occur and the successful implementation of deprescribing psychotropic medications.
Similar articles
-
Psychotropic medication deprescribing in residential aged care facilities: An exploratory study of the knowledge and attitudes of family members of residents with dementia.Australas J Ageing. 2022 Dec;41(4):e356-e363. doi: 10.1111/ajag.13043. Epub 2022 Feb 15. Australas J Ageing. 2022. PMID: 35166431 Free PMC article.
-
Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.Int Psychogeriatr. 2017 Aug;29(8):1391-1403. doi: 10.1017/S1041610217000084. Epub 2017 Mar 7. Int Psychogeriatr. 2017. PMID: 28266282
-
A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol.Trials. 2022 May 16;23(1):410. doi: 10.1186/s13063-022-06368-9. Trials. 2022. PMID: 35578351 Free PMC article.
-
Deprescribing psychotropic medications in aged care facilities: the potential role of family members.Adv Exp Med Biol. 2015;821:29-43. doi: 10.1007/978-3-319-08939-3_8. Adv Exp Med Biol. 2015. PMID: 25416108 Review.
-
Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review.Curr Clin Pharmacol. 2015;10(3):168-77. doi: 10.2174/157488471003150820150330. Curr Clin Pharmacol. 2015. PMID: 26338170 Review.
Cited by
-
Factors associated with eating performance in nursing home residents living with dementia and other comorbidities.BMC Geriatr. 2024 Nov 15;24(1):946. doi: 10.1186/s12877-024-05540-x. BMC Geriatr. 2024. PMID: 39548398 Free PMC article.
-
Factors promoting and impeding efforts to deprescribe antidepressants among nursing home residents with dementia- a process evaluation guided by normalization process theory.BMC Nurs. 2024 Apr 28;23(1):287. doi: 10.1186/s12912-024-01932-x. BMC Nurs. 2024. PMID: 38679697 Free PMC article.
-
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study.Int J Clin Pharm. 2024 Aug;46(4):889-898. doi: 10.1007/s11096-024-01723-z. Epub 2024 Apr 20. Int J Clin Pharm. 2024. PMID: 38642248
-
Young-onset dementia diagnosis, management and care: a narrative review.Med J Aust. 2023 Mar 6;218(4):182-189. doi: 10.5694/mja2.51849. Epub 2023 Feb 19. Med J Aust. 2023. PMID: 36807325 Free PMC article. Review.
-
Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia.BMC Health Serv Res. 2022 Dec 26;22(1):1582. doi: 10.1186/s12913-022-08961-9. BMC Health Serv Res. 2022. PMID: 36572903 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
